As India entered a strict nationwide lockdown to counter COVID-19, 1mg — the nation’s largest integrated online health platform — rushed to ensure the continued flow of regular health supplies and testing services to its customers.
The company, which has served more than 150 million customers with medicines, lab tests, and a wide range of other health-related products and services, saw a jump in demand for flu and fever e-consultations. It met this demand, alongside existing customer commitments, by signing up new doctors, securing government permission to carry out essential deliveries, and creating workplace sanitation procedures to protect employees.
A $12.5 million IFC equity investment in FY19 and FY20 helped 1mg to grow its platform.
1mg intends to replicate its success and scale up, and also to stimulate and invite market competition in providing health care in a country with 1.3 billion residents in need of services. The company is a lifeline for its customers, especially those who live in smaller towns and rural areas and rely on 1mg’s deliveries to treat chronic conditions.
“We are all witnessing a new model of health care, led by patient-centric design, as 1mg has always believed to be the right way. Digitally enabled, real-time access to pharmacy, labs, and doctors is going to be the new norm,” said Prashant Tandon, co-founder and CEO of 1mg. “This is our opportunity to be game changers, and to change the entire health infrastructure in a lasting way, for the better.”